Table 1 VISTA expression and its association with the clinicopathologic parameters of patients with endometrial cancer.

From: Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer

Parameters

N

VISTA in ICs

P-value

VISTA in TCs

P-value

Negative N

Positive N (%)

Negative N

Positive N (%)

Age (N = 839)

   

0.308

  

0.003

 <58 years

412

90

322 (78.2)

 

395

17 (4.1)

 

 ≥58 years

427

106

321 (75.2)

 

387

40 (9.4)

 

FIGO stage (N = 804)

  

0.001

  

0.695

 I

546

118

428 (78.4)

 

512

34 (6.2)

 

 II

39

4

35 (89.7)

 

35

4 (10.3)

 

 III

174

42

132 (75.9)

 

161

13 (7.5)

 

 IV

45

20

25 (55.6)

 

43

2 (4.4)

 

Tumor grade (N = 839)

  

0.10

  

0.121

 Low

407

85

322 (79.1)

 

385

22 (5.4)

 

 High

432

111

321 (74.3)

 

397

35 (8.1)

 

Histology (N = 839)

   

0.071

  

<0.001

 Endometrioid

596

130

466 (78.2)

 

567

28 (4.7)

 

 Serous

114

27

87 (76.3)

 

105

9 (7.9)

 

 Clear cell

47

10

37 (78.7)

 

33

14 (29.8)

 

 Carcinosarcoma

54

21

33 (61.1)

 

49

5 (9.2)

 

 Others

28

8

20 (71.4)

 

27

1 (3.5)

 

Myometrial invasion (N = 809)

 

0.112

  

0.477

 <1/2

588

126

462 (78.6)

 

551

37 (6.3)

 

 ≥1/2

221

59

162 (73.3)

 

204

17 (7.7)

 

LVSI (N = 813)

   

0.561

  

0.257

 Absent

585

132

453 (77.4)

 

542

43 (7.4)

 

 Present

233

57

176 (75.5)

 

221

12 (5.2)

 

Mismatch repair (N = 829)

  

<0.001

  

0.437

 Proficient

615

166

449 (73.0)

 

571

44 (7.2)

 

 Deficient

214

27

187 (87.4)

 

202

12 (5.6)

 

Molecular subgroup (N = 598)

 

<0.001

  

0.50

POLEmut

51

5

46 (90.2)

 

49

2 (3.9)

 

 MMRd

163

23

140 (85.9)

 

153

10 (6.1)

 

 NSMP

246

68

178 (72.4)

 

232

17 (6.8)

 

 p53mut

132

44

88 (66.7)

 

122

13 (9.6)

 

PD-L1 (N = 833)

   

<0.001

  

0.304

 Negative

457

156

301 (65.9)

 

422

35 (7.7)

 

 Positive

376

39

337 (89.6)

 

354

22 (5.9)

 

Density of CD8+ T cell (N = 837)

 

<0.001

  

0.928

 Low

416

127

289 (69.4)

 

388

28 (6.7)

 

 High

421

68

353 (83.8)

 

392

29 (6.9)

 
  1. FIGO International Federation of Gynecology and Obstetrics, ICs immune cells, LVSI lymphovascular space invasion, MMRd mismatch repair-deficient, NSMP nonspecific molecular profile, p53mut P53 mutation, PD-L1 programmed cell death-ligand 1; POLEmut polymerase epsilon mutation, TCs tumor cells, VISTA V-domain Ig suppressor of T-cell activation.